Earnings
NLTX
10.40
-2.16%
-0.23
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2020-12-31
0.00
--
--
--
17.21M
24.34M
--
--
--
33.73M
--
-33.73M
495.00K
--
-44.00K
--
-33.28M
--
-33.28M
--
-33.28M
-33.28M
--
--
-0.64
FY 2019-12-31
0.00
0.00
--
--
18.13M
6.32M
--
--
--
70.96M
--
-70.96M
1.52M
--
-8000.00
--
-69.44M
--
-69.44M
--
-69.44M
-69.44M
--
--
-2.57
FY 2018-12-31
25.00M
25.00M
--
--
15.84M
41.79M
--
--
--
57.62M
--
-32.62M
1.48M
--
-445.00K
--
-31.59M
--
-31.59M
--
-31.59M
-31.59M
--
--
-1.34
FY 2017-12-31
0.00
0.00
--
--
14.85M
36.27M
--
--
--
51.12M
--
-51.12M
975.00K
--
-39.00K
--
-50.18M
2.30M
-52.48M
--
-52.48M
-52.48M
2.30M
--
-2.24
FY 2016-12-31
0.00
0.00
--
--
9.26M
28.38M
--
--
--
37.65M
--
-37.65M
686.00K
--
-43.00K
--
-37.00M
--
-37.00M
--
-37.00M
-37.00M
--
--
-1.96

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out NLTX latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Neoleukin Therapeutics recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.